InnovAge prices 10 million shares at USD 9.25 for InnovAge stock

Published on 10/05/2026 at 05:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 15.9 percent to USD 989.7 million in fiscal 2026. For InnovAge stock this means a 1.5 million-share option and 8,230 participants.

INNV, US45784A1043, Illustration mit AI erstellt.

InnovAge Holding Corp. (ISIN US45784A1043) priced 10,000,000 shares at USD 9.25 for InnovAge stock in a secondary offering announced on September 22, 2026. The transaction involved existing holders rather than a new share issue by the healthcare provider, making supply and ownership the central market questions.

Secondary sale changes the supply picture

According to The Globe and Mail on September 25, 2026, the offering closed with delivery and payment on September 24. Selling stockholders offered 10,000,000 shares at USD 9.25 and granted underwriters an option for another 1,500,000 shares.

InnovAge said on September 22, 2026, that the selling stockholders were investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. InnovAge itself is not selling shares or receiving proceeds, but it will bear offering costs apart from underwriting discounts and commissions.

Revenue growth meets execution risks

Yahoo Finance reported on September 9, 2026, that fiscal 2026 revenue increased 15.9 percent to USD 989.7 million. Adjusted EBITDA rose 175.0 percent to USD 94.6 million, while the company recorded a fiscal 2026 net loss of USD 0.7 million after legal accruals.

The operating picture also includes a measurable enrollment gain. Fiscal 2026 census increased 6.3 percent to approximately 8,230 participants, while center-level contribution margin improved by 500 basis points to 23.0 percent of revenue.

What the sale means for valuation

As of June 30, 2026, InnovAge served approximately 8,230 participants across 20 centers in six states, according to InnovAge. The scale supports the revenue trajectory, but the fiscal 2027 outlook depends more heavily on enrollment, utilization management and regional rate decisions.

Yahoo Finance reported fiscal 2027 guidance for revenue of USD 1.05 billion to USD 1.085 billion and adjusted EBITDA of USD 105.0 million to USD 115.0 million. The revenue guidance midpoint of USD 1.0675 billion is 7.86 percent above fiscal 2026 revenue of USD 989.7 million, providing a quantified benchmark for the next operating phase.

Market range frames the next move

As of October 2, 2026, InnovAge had a market capitalization of USD 1.2 billion and a 52-week trading range of USD 3.94 to USD 12.64. The company is listed on Nasdaq under ticker INNV, and the secondary transaction gives investors a dated USD 9.25 reference for the level at which existing holders sold shares.